Alkermes Looks To Capitalize On Opioid Epidemic Through Aggressive Lobbying
June 12, 2017 at 12:00 PM EDT
The U.S. Food and Drug Administration's quest to address the growing opioid crisis is hurting many pharmaceutical companies, including ...